Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience.
Saved in:
| Title: | Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience. |
|---|---|
| Authors: | Suresh A; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA.; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA., Ganju A; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA.; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA., Morgan E; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA.; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA., Palettas M; Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, OH, USA., Stephens JA; Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, OH, USA., Liu J; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA.; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA., Berger M; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA.; Pharmacy Department, Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA., Vargo C; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA.; Pharmacy Department, Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA., Noonan A; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA.; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA., Reinbolt R; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA.; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA., Cherian M; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA.; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA., VanDeusen J; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA.; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA., Sardesai S; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA.; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA., Wesolowski R; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA.; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA., Stover DG; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA.; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA., Lustberg M; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA.; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA., Ramaswamy B; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA.; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA., Williams N; Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA. Nicole.Williams@osumc.edu.; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA. Nicole.Williams@osumc.edu.; Division of Medical Oncology, The Ohio State University Wexner Medical Center, 1202A Lincoln Tower, 1800 Cannon Drive, Columbus, OH, 43210, USA. Nicole.Williams@osumc.edu. |
| Source: | Investigational new drugs [Invest New Drugs] 2020 Oct; Vol. 38 (5), pp. 1605-1611. Date of Electronic Publication: 2020 Jan 14. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-0646 |
|---|---|
| DOI: | 10.1007/s10637-020-00891-9 |
